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Myocarditis, inflammation of the heart muscle, affects all demographics and is a major
cause of sudden and unexpected death in young people. It is most commonly caused
by viral infections of the heart, with coxsackievirus B3 (CVB3) being among the most
prevalent pathogens. To understand the molecular pathogenesis of CVB3 infection and
provide strategies for developing treatments, we examined the role of a key nuclear pore
protein 98 (NUP98) in the setting of viral myocarditis. NUP98 was cleaved as early as
2 h post-CVB3 infection. This cleavage was further verified through both the ectopic
expression of viral proteases and in vitro using purified recombinant CVB3 proteases
(2A and 3C), which demonstrated that CVB3 2A but not 3C is responsible for this
cleavage. By immunostaining and confocal imaging, we observed that cleavage resulted
in the redistribution of NUP98 to punctate structures in the cytoplasm. Targeted siRNA
knockdown of NUP98 during infection further increased viral protein expression and viral
titer, and reduced cell viability, suggesting a potential antiviral role of NUP98. Moreover,
we discovered that expression levels of neuregulin-1 (NRG1), a cardioprotective gene,
and presenilin-1 (PSEN1), a cellular protease processing the tyrosine kinase receptor
ERBB4 of NRG1, were reliant upon NUP98 and were downregulated during CVB3
infection. In addition, expression of these NUP98 target genes in myocardium tissue
not only occurred at an earlier phase of infection, but also appeared in areas away
from the initial inflammatory regions. Collectively, CVB3-induced cleavage of NUP98 and
subsequent impairment of the cardioprotective NRG1-ERBB4/PSEN1 signaling cascade
may contribute to increased myocardial damage in the context of CVB3-induced
myocarditis. To our knowledge, this is the first study to demonstrate the link between
NUP98 and the NRG1 signaling pathway in viral myocarditis.
Keywords: CVB3, NUPs, NUP98, NRG1, ERBB4, PSEN1, protease, myocarditis
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INTRODUCTION

addition, poliovirus 2A protease can target NUP98, NUP62
and NUP153 for cleavage during the course of infection (Park
et al., 2008), resulting in the cellular relocalization of NUPs. This
cleavage benefits poliovirus replication (Fitzgerald et al., 2013).
However, with respect to CVB3, a close relative of poliovirus that
also replicates in membrane vesicles within the cytoplasm but
causes different diseases, whether proteases can cleave NUPs in
order to augment pathogenesis is unknown.
The nuclear pore complex is a 125 MDa complex made
up of over 40 different proteins (Liang et al., 2013; Cautain
et al., 2015). NUPs were traditionally thought to be mere
“gatekeepers” of the nucleus, regulating the translocation
of nuclear resident proteins and RNA in and out of the
nucleus. In recent years, multiple, dynamic functions, such as
transcriptional activation or repression, have been described,
whereby NUPs migrate from the nuclear periphery and interact
directly with chromatin or as direct transcription factors.
One NUP in particular, NUP98, performs both nuclear gatekeeping functions, as well as acting as an immune-responsive
transcription factor (Panda et al., 2014, 2015). This dual
function of NUP98 has been demonstrated during human
development and in various pathological conditions (Xu and
Powers, 2009; Franks and Hetzer, 2013; Lussignol et al.,
2016). During human heart development, NUP98 has been
shown to be a transcription factor for neuregulin-1 (NRG1)
(Liang et al., 2013), a protein which plays an integral role
during development in trabeculation and myocyte proliferation
resulting in the thickening and proper functioning of the
ventricles. The interaction between NRG1 and its tyrosine kinase
receptor, epidermal growth factor ERBB4, has also been shown
to be beneficial in promoting cardioprotective effects postischemia (Wang et al., 2018) as well as being involved in host
cell response to infection (Ho et al., 2017). Therefore, NRG-1
and its receptor ERBB4 may be of central importance to the
recovery from acute and chronic CVB3 induced myocarditis.
Additionally, Presenilin-1 (PSEN1), a cellular protease and
component of the γ-secretase complex, has been demonstrated
to cleave ERBB4 and translocate with it to the nucleus in
cells undergoing apoptosis (Vidal et al., 2005). Indeed, NRG1, PSEN1 and ERBB4 dysfunction have been described as
key contributors in the pathogenesis of cancer, cardiovascular
disease, and neurological disorders (Woo et al., 2011; Cui
et al., 2013; Vasti and Hertig, 2014). However, whether this
finding can fill the knowledge gap in our understanding of
molecular pathogenesis of CVB3-induced viral myocarditis has
not been investigated.
In the present study, we sought to understand the role of
NUP98 in the pathogenesis of viral myocarditis and its impact
on the hypothetically cardioprotective NRG1-ERBB4/PSEN1
signaling axis. We demonstrate that NUP98 is targeted early
during CVB3 infection for cleavage by viral protease 2A. This
cleavage leads to redistribution of NUP98 from the nucleus to
the cytoplasm, where it forms punctuate structures. Further,
knockdown of NUP98 resulted in dramatic reduction of its
transcriptional targets leading to impaired cardioprotection,
increased viral titer and decreased cell viability during infection.
Additionally, Nup98, Nrg1, and erbB4 were all upregulated in the

Myocarditis, defined as inflammation of the myocardium,
encompasses a spectrum of conditions causing considerable
morbidity and mortality. There are considerable gaps in our
knowledge relating to the molecular pathogenesis of the disease
(Feldman and McNamara, 2000). Although myocarditis affects
all demographics, it is among the leading causes of sudden
and unexpected death in children and young adults, with
males being preferentially affected as compared to females.
Long-term manifestations of myocarditis include arrhythmia,
chronic active myocarditis and dilated cardiomyopathy (DCM),
all of which may result in heart failure. Viruses are the
major causal agents of infectious myocarditis (Feldman and
McNamara, 2000). Coxsackievirus B3 (CVB3) is among the most
prevalent cardiotropic pathogens of viral myocarditis (Yajima
and Knowlton, 2009) and has been implicated in ∼20% of acute
onset heart failure and DCM (Baboonian and Treasure, 1997;
Baboonian et al., 1997). At the present, treatment for myocarditis
is mostly supportive and there is no widely approved specific
therapy or vaccine for CVB3 (Abelmann, 1971; McManus et al.,
1988; Schultheiss et al., 2011). For DCM patients, the only
definitive treatment thus far is mechanical assist devices and/or
heart transplantation.
CVB3 is a positive, single-stranded RNA virus in the genus
enterovirus of family Picornaviridae; its genome encodes a single
long open reading frame flanked by the 5′ and 3′ untranslated
regions (UTR). Unlike the cellular mRNAs that link to a
m7 G(5′ )ppp(5′ )N cap structure at the 5′ terminus, the CVB3
genome is attached with a small viral peptide, VPg and its 5′ UTR
harbors an internal ribosome entry site (IRES), which drives the
translation of viral RNA via a cap-independent mechanism (Liu
et al., 1999). The translated long polyprotein can be processed by
viral proteases 2A and 3C into four structural (VP1-4) and seven
non-structural proteins, including proteases 2A and 3C as well
as other proteins used for viral RNA replication and infectious
particle assembly (Sin et al., 2015; Fung et al., 2016). Enteroviral
proteases have been well-documented in their roles to suppress
multiple host cell activities via cleavage of cellular proteins,
For example, enterovirus proteases can cleave eukaryotic
transcription factors and activators (Yalamanchili et al., 1997;
Castello et al., 2011). Protease 2A can cleave eukaryotic initiation
factors 4GI (eIF4GI) (Lamphear et al., 1995; Lamphear and
Rhoads, 1996; Chau et al., 2007) and eIF4GII (Gradi et al., 1998;
Svitkin et al., 1999) shutting down cap-dependent translation.
In addition, some enterovirus proteases can also cleave cellular
structure proteins, such as dystrophin and nucleopore proteins
(NUPs) that are involved in maintaining cellular integrity and
functions (Xiong et al., 2002; Park et al., 2008).
All positive-polarity single-stranded RNA viruses are
cytoplasmic viruses, which recruit and rearrange host cellular
membranes to form vesicles for viral replication (Schwartz
et al., 2004). For example, Hepatitis C virus (HCV) induces
sub-cellular redistribution of NUPs to the cytoplasm, where
they accumulate at sites enriched for HCV proteins and viral
assembly (Neufeldt et al., 2013). Furthermore, the depletion
of NUPs via siRNA knockdown inhibits HCV replication. In
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Western Blot Analysis

murine myocardium during acute/early phase of CVB3 infection,
and Nrg-1 and erbB4 were downregulated at a later phase of
infection, suggesting a cardioprotective role of this signal cascade
in cellular response to infection.

All Western blot analyses were conducted using previously
described standard protocols (Felker et al., 1999). Mouse heart
tissue was sectioned from the apical tissue and homogenized
in 1% Triton X-100 MOSLB lysis buffer containing protease
inhibitor cocktail. Tissue lysates were centrifuged at 4◦ C, 13,000
× g for 20 min. The supernatants were collected and protein
concentrations were measured using the Bradford Assay (BioRad Laboratories, Mississauga, ON). Cells were washed twice
in cold PBS after transfection or infection at different time
points mentioned above. Cells were lysed in lysis buffer (0.025 M
Tris-HCl, pH 8.0, 137 mM NaCl, 10% glycerol, 1 mM EDTA,
1 mM EGTA, 1%Triton X-100 and protease inhibitor cocktail)
on ice for 20 min. Supernatants containing proteins were isolated
by centrifugation at 13,000 × g at 4◦ C for 15 min. Proteins
were separated by 10% SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred onto nitrocellulose membranes
(Amersham). Membranes were blocked in 5% skim milk in Trisbuffered saline 10% tween (TBST) buffer for 1 h and subsequently
incubated with one of the following primary antibodies against
NUP98 (Cell signaling), Neuregulin-1 and ERBB4 (Thermo
Fisher), PSEN1 (Abcam), VP1 (Dako), and β-actin (Santa Cruz)
at 4◦ C overnight. Membranes were subsequently washed in TBST
three times for 10 min each, followed by incubation with the
appropriate secondary antibody (goat anti-mouse or donkey
anti-rabbit) conjugated to horseradish peroxidase (Amersham)
and visualized using the enhanced chemiluminescence method
as per the manufacturer’s instructions (Amersham). Protein
expression was quantified by densitometry using the NIH
ImageJ software package (http://imagej.nih.gov/ij/index.html)
and normalized to GAPDH or β-actin as indicated based upon
an n of 3 for each experiment and depicted graphically next to
each blot in the figure. Sham values were normalized to 1.00.

MATERIALS AND METHODS
Virus, Cells, Plasmids, and Animals
CVB3 (CG) strain was obtained from Dr. Charles Gauntt
(University of Texas Health Science Center, San Antonio,
TX) and propagated in HeLa cells (ATCC). Virus stock was
isolated from cells by three freeze-thaw cycles followed by
centrifugation to remove cell debris, and stored at −80◦ C.
Virus stock titer was determined by plaque assay as described
in a later section. HeLa cells were grown and maintained in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal bovine serum (FBS) (Clontech, Palo Alto,
CA), 100 µg/ml penicillin, 100 µg/ml streptomycin, and 2 mM
glutamine. Plasmid construction of pIRES-2A and pIRES-3C was
previously described (Fung et al., 2013). NUP98-GFP plasmid
was a generous gift from the Fahrenkrog laboratory at the
Université Libre de Bruxelles, Belgium. The animal experiments
were carried out in accordance with the recommendations in
the Guide to the Care and Use of Experimental Animals—
Canadian Council on Animal Care. All of the animal protocols
were approved by the Animal Care Committee, University of
British Columbia (protocol number: A16-00593). Four-weeks
old male A/J mice were purchased from Jackson Laboratories
(Maine, USA). Ten mice in two groups were infected with
104 plaque forming units (PFU) of CVB3 or sham infected
with phosphate-buffered saline (PBS) (Sigma, St. Louis, MO) by
intraperitoneal inoculation. Mice were monitored and sacrificed
at the corresponding day post-infection (dpi). Seven dpi
represents the acute phase of infection and 40 dpi represents
the chronic phase. Hearts were harvested and a transverse
section through the ventricles was fixed for at least 24 h in
10% phosphate-buffered formalin. The tissues were embedded
in paraffin blocks and 4-µm tissue sections were stained with
hematoxylin and eosin (H&E) for assessment of myocardial
inflammation or via immunohistochemistry for determining
protein expression (see section below).

In vitro Protein Cleavage Assay
Recombinant CVB3 wild-type and catalytically inactive mutant
2A and 3C proteases were purified as described previously
(Jagdeo et al., 2018). For cleavage assays, 25 µg of wholecell lysates prepared from HeLa cells was incubated with
CVB3 2A (5 ng/µl) or CVB3 3C (100 ng/µl) at 37◦ C
for 4 h in reaction buffer [20 mM Hepes (pH7.4), 150 mM
KOAc, and 1 mM DTT] (Park et al., 2015). After this
incubation, samples were analyzed by Western blot analysis as
described above.

Transfection and Virus Infection

Immunocytochemistry

HeLa cells growing in 6-well plates at 70–80% confluence were
washed with PBS and overlaid for 48 h with transfection complex
containing 2 µg of plasmid DNA and 10 µl of lipofectamine
2000 (Invitrogen) reagent per well. siRNA specific to human
NUP98 or scrambled siRNA (Santa Cruz) was transfected at
a final concentration of 10 µM for 48 h using oligofectamine
reagent. The transfection medium was then replaced with DMEM
containing 10% FBS and the incubation was continued for 24 h
prior to viral infection, or 48 h prior to harvesting. For viral
infection, cells were washed with PBS and infected in 500 µl of
serum-free DMEM at a multiplicity of infection (MOI) of 10 or
sham-infected with PBS for 3, 5, or 7 h.
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HeLa cells proliferating on glass coverslips in a 6-well plate
at ∼70% confluence were transfected with pIRES-vector,
pIRES-2A or pIRES-3C. At 48 h post-transfection, cells were
stained as described previously (Felker et al., 2000). Briefly,
cells were fixed with 4% paraformaldehyde, permeabilized in
methanol/acetone (50:50) at −20◦ C for 20 min and stained
with an anti-NUP98 primary antibody (Cell signaling). Slides
were washed and stained with a goat anti-rabbit IgG (H +
L) labeled with ALEXA Fluor 488 (Invitrogen). Nuclei were
stained with 4′ ,6′ -diamidine-2′ -phenylindole dihydrochloride
(DAPI) (Vector Laboratories). Cells were observed under a
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Cell Viability Assay

Leica SP2 AOBS confocal microscope. Mouse hearts were
harvested from 4-weeks old CVB3-infected A/J mice and fixed
in 10% formalin (Fisher) for at least 24 h. Hearts were then
imbedded in paraffin and sectioned in 4 µM sections onto
slides for staining. For evaluation of inflammation and damage,
Hematoxylin and Eosin (H&E) staining was conducted by
following the method described previously (Wang et al., 2011).
For immunochemistry staining, sections were deparaffinized,
rehydrated and subjected to citrate buffer (pH 6.0, Invitrogen)
heat-induced antigen retrieval. Slides were washed in TBS
and blocked for 30 min in TBS/5% BSA solution at room
temperature. Slides were incubated overnight at 4◦ C with a
primary antibody (NUP98, NRG-1, PSEN1, or ERBB4) diluted
in TBS/1% BSA according to the manufacturer’s suggestion.
The following day, the slides were treated with Mach 4 polymer
detection complex-alkaline phosphatase (Biocare Medical,
USA) amplification step followed by Warp Chromogen Red
(Biocare Medical) as the substrate. Hematoxylin was used to
counterstain cell nuclei. Bright field imaging under the Nikon
Eclipse E600 microscope (Nikon, El Segundo, USA) was digitally
captured using a SpotFlex camera (Diagnostic Instruments,
Sterling Heights, USA), with n = 3 mouse hearts for each antigen
detected. Proportion of Positive Area (PPA) Image analysis was
performed on the Aperio ImageScopeTM following analysis
workflow recommended by the Aperio ImageScopeTM User’s
Guide
(https://www.leicabiosystems.com/digital-pathology/
manage/aperio-imagescope/) (Kalra et al., 2015). Tissues were
traced to indicate area for image analysis, while artifacts, such
as folded regions of tissue were removed from the analysis.
PPA was calculated by adding the number of positive and
number of strong positive counts, then dividing this sum by
the total number of positive and negative counts as provided
by image analysis results. Differential expression of Nup98,
erbB4 and Nrg1 in sham infected vs. CVB3 infected murine
myocardium at the indicated dpi (n = 3) were quantified using
a fold change value. This value was calculated by dividing
the number of positive and strong positive signal by the total
number of positive signal and negative signal. The average PPA
of three sham infected hearts was set to 1.00. Therefore, the fold
change value is effectively an expression of protein expression
normalized to sham infected heart tissue. Statistical analyses are
described below.

HeLa cell viability was quantified using a 3-(4-5-dimethylthiazol2-yl)-5-(-3-carboxymethoxyphenyl)-2H-tetrazolium salt (MTS)
assay kit following the manufacturer’s instructions (Promega).
Cells were transfected with siRNA specific to human NUP98 or
scrambled siRNA. Transfected cells were infected with CVB3 at
an MOI of 10 or sham-infected with PBS (see transfection and
virus infection section above). Briefly, cells were incubated with
MTS solution for 4 h. Absorbency of formazan was measured at
492 nm using an enzyme-linked immunosorbent assay (ELISA)
plate reader with n ≥ 3 for each time point. Absorbency of
sham infected/scrambled siRNA treated cells was defined as 100%
viability (control) and the remaining data were converted to a
percentage of the control.

Statistical Analysis
Student’s t-test was employed to analyze the data. Results
are expressed as means ± standard deviation of three
independent experiments. A P-value <0.05 was considered
statistically significant.

RESULTS
NUP98 Is Cleaved by Viral Protease 2A but
Not 3C During CVB3 Infection
To determine whether NUP98 is cleaved during CVB3 infection,
HeLa cells were infected with CVB3 at a MOI of 10 or
sham-infected with PBS. Sham-infected cells were collected
corresponding to the collection of the final CVB3-infected time
point (i.e., 8 hpi). Western blot analysis of HeLa cell proteins
was conducted using an anti-NUP98 (targeting N-terminal to
mid region of NUP98) antibody. Figure 1A demonstrates that a
∼55 kDa cleavage fragment of NUP98 was generated by 3 h postinfection (hpi) from its 98 kDa proform. Further, a secondary
∼43 kDa cleavage fragment of Nup98 was observed at 4 hpi.
This ∼43 kDa fragment increased in abundance throughout
the duration of the infection (7 h). To further verify the viral
protease-mediated cleavage, in vitro cleavage assay using purified
recombinant CVB3 proteases 2A and 3C incubated with proteins
extracted from non-infected HeLa cell lysates was conducted
(Jagdeo et al., 2018) (Figure 1B). Additionally, two controls were
included: (i) CVB3 infected cell lysates collected at 7 hpi served
as a positive control; (ii) recombinant 2A or 3C with the catalytic
site mutation (2Amut or 3Cmut ) were incubated with HeLa cell
lysates for 16 h, which served as negative controls. Figure 1B
demonstrates that only protease 2A could cleave NUP98 to
produce a ∼43 kDa fragment, which is the same size as that
produced by CVB3 infection. These data suggest that viral
protease 2A but not 3C is responsible for the cleavage of NUP98
during CVB3 infection.

Viral Plaque Assay
Viral titers were determined as previously described (Yuan et al.,
2009). Briefly, HeLa cells were seeded into 6-well plates (8 ×
105 cells/well) and incubated at 37◦ C for 20 h to a confluence of
∼90%, then washed with PBS and overlaid with 500 µl of virus
serially diluted in cell-culture medium. Viruses were obtained
by centrifugation (4,000 × g) of freeze-thawed cell suspensions
as described above. After a viral-adsorption period of 60 min at
37◦ C, the supernatant was removed, the cells overlaid with 2 ml of
sterilized soft Bacto-agar-minimal essential medium, cultured at
37◦ C for 72 h, fixed with Carnoy’s fixative for 30 min, and stained
with 1% crystal violet. The plaques were counted and PFU per
ml calculated.
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CVB3 Infection Induces the Redistribution
of NUP98 to Cytoplasmic Punctate
Structures
To examine whether CVB3-induced cleavage of NUP98 caused
redistribution of NUP98 during infection, confocal microscopy
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FIGURE 1 | NUP98 is cleaved by viral protease 2A during CVB3 infection. (A) NUP98 cleavage in CVB3-infected HeLa cells. HeLa cells were infected with CVB3 or
sham-infected with PBS. At the indicated time points post-infection (pi), cell lysates were harvested for western blot analysis of NUP98 cleavage products. VP1, a viral
capsid protein, was used to represent viral replication. β-actin was used as a loading control. Molecular weight markers in kDa are indicated. (B) In vitro cleavage
assay. Non-infected HeLa cells lysates were incubated overnight with purified recombinant viral protease 2A, 3C, 2Amut , or 3Cmut (mut indicates mutated, inactive
catalytic sites). Lysates were subjected to western blot analysis of NUP98 cleavage products. CVB3-infected cell lysate harvested at 7 h pi was used as a positive
control. β-actin was used as a loading control.

likely due to cellular upregulation of NUP98 in response
to CVB3 infection. At 6 hpi, NUP98 was observed in
punctate structures mostly in the cytoplasm. Since we had
verified that 2A was responsible for NUP98 cleavage, we
wondered if the observed redistribution of NUP98 in punctate
pattern could be triggered by expression of viral protease
2A alone.

was employed to observe its sub-cellular distribution after
infection. HL-1 cardiomyocytes were infected with CVB3 at 10
MOI and fixed at 2, 4, and 6 hpi. Cells were immunostained
with the primary NUP98 antibody, followed by Alexa 488conjugated secondary antibody for confocal observation. As
shown in Figure 2, NUP98 migrated from the nuclear periphery
at 4 hpi into the nucleoplasm, where the signal was enhanced,
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FIGURE 2 | CVB3 infection induces the sub-cellular redistribution of NUP98 in cardiomyocytes. Mouse HL-1 cardiomyocytes were sham-infected with PBS or
infected with CVB3 for 2–6 h. Cells were fixed and immunostained using a NUP98 specific antibody. Blue represents the nuclei stained with DAPI and green shows
NUP98 protein. Beginning at 4 hpi, NUP98 was relocalized to the cytoplasm in punctate structures, becoming most apparent at 6 hpi. Cells were observed at each
time-point by confocal microscopy at 20× magnification. Scale bars = 20 µm.

Ectopic Expression of Viral Protease 2A Is
Sufficient to Induce the Sub-Cellular
Redistribution of NUP98 to Punctate
Cytoplasmic Structures

siRNA Knockdown of NUP98 Differentially
Regulates Cardioprotective and Viral Gene
Expression While Overexpression of
NUP98 Produces the Inverse Effect

To determine if viral protease 2A alone could induce the
subcellular redistribution of NUP98 during CVB3 infection,
HeLa cells were transfected with a plasmid expressing the
2A (pIRES-2A), 3C (pIRES-3C), or empty vector (pIRES) for
48 h in the absence of CVB3 infection and subsequently fixed
and immunostained for confocal microscopy examination. As
demonstrated in Figure 3, ectopic expression of protease 2A
induced the subcellular redistribution of NUP98 from the
nuclear periphery to nucleoplasm and then to cytoplasm as
compared to vector transfected cells where NUP98 remained
localized to the nuclear periphery. This result suggests that
2A expression is sufficient to induce a similar accumulation
and subcellular redistribution of NUP98 in punctate structures
as seen at 6 h post-CVB3 infection in Figure 2. Intriguingly,
ectopic expression of viral protease 3C in the absence of viral
infection appeared to induce the upregulation and redistribution
of NUP98 to the nucleoplasm, as compared to vector transfected
cells where NUP98 is observed mostly at the nuclear periphery
(see Discussion).

Previous studies report that NUP98 acts as a transcription factor
for NRG1 during human development (Liang et al., 2013).
Additionally, NRG1 has been used in clinical trials for the
treatment of myocardial infarction in which increased cardioprotective effects were observed. NRG1 binding to its receptor
ERBB4 activates pathways which promote cardiac myocyte
survival, sarcomeric organization, cell to cell contact and cardiac
pumping (Xu et al., 2010).
To examine the effect of NUP98 knockdown during CVB3
infection on the expression of NRG1, ERBB4, PSEN1 and
viral capsid protein VP1 (a marker of viral protein synthesis),
siRNA targeting NUP98 (siNUP98) or scrambled siRNA was
transfected into HeLa cells 48 h prior to infection with CVB3
or sham-infection with PBS. Lysates were collected from
sham-infected and CVB3-infected cells at 3, 5, and 7 hpi.
Western blot analysis confirmed the successful knockdown
of NUP98 by siRNA (Figure 4). Following a decrease in
NUP98 levels after siNUP98 knockdown, NRG1 levels in shaminfected/scrambled siRNA-treated cells were ∼3-fold higher than
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FIGURE 3 | Ectopic expression of viral protease 2A or 3C results in differential sub-cellular redistribution of NUP98. HeLa cells were transfected with plasmid
expressing viral protease 2A or 3C or with empty vector for 24 h. Cells were fixed and immunostained as described in Figure 2. Cells were visualized by confocal
microscopy, images are shown at 60× magnification. Blue represents the nuclei stained with DAPI and green shows NUP98 protein. Scale bars = 5 µm.
2A transfected cells show NUP98 redistributed to the cytoplasm, indicating cleavage.

cells also decreased the resulting level of NRG1 at 5 and 7
hpi (after an initial increase in NRG1 levels at 3 hpi induced
by NUP98 overexpression) (Figures 4C,D, lane 5–6 vs. 7–8).
Although PSEN1 and ERBB4 expression only showed a slight
change, the dramatic increase in NRG1 expression caused a
significant decrease of VP1 level.
The significance of these data is 2-fold: first, CVB3 infection
can reduce the NUP98-mediated up-regulation of cardioprotective NRG1, which is likely attributed to the cleavage of
NUP98 by CVB3 protease 2A. Second, the siNUP98 treatment
further enhances the CVB3-induced downregulation of NRG1
via silencing of NUP98, whereas overexpression of NUP98 has
the opposite effect.

that in siNUP98 treated/sham-infected cells (Figures 4A,B, lane
1 vs. 5), indicating that NUP98 upregulates NRG1 in the absence
of CVB3 infection. Interestingly, NRG1 expression levels during
infection were significantly lower in siNUP98 treated cells than in
scrambled siRNA treated cells (Figures 4A,B, lane 6–8 vs. 2–4),
particularly at 7 hpi, the decrease is ∼20-fold (lane 4 vs. 8). Other
proteins including PSEN1 and ERBB4 were also decreased in
siNUP98-treated cells compared to their controls; but CVB3 VP1
was significantly increased in siNUP98 treated cells compared to
the scrambled siRNA treated control (lane 3 vs. 7). However, at 7
hpi, the VP1 level only had a slight increase, which is likely due
to the complete cleavage of NUP98.
‘To observe the effect of NUP98 overexpression on its
target gene during CVB3 infection, GFP-NUP98 plasmid or
GFP vector was transfected into HeLa cells, infected with 10
MOI CVB3 and collected at 3, 5, 7 hpi. Following an increase
in NUP98 levels, NRG1 protein expression increased in both
sham- and CVB3-infected cells relative to vector transfected cells
(Figures 4C,D, lane 5–6 vs. 1–2), confirming a regulatory role
for NUP98 on NRG1 expression in presence and absence of
CVB3 infection. CVB3 infection in NUP98 plasmid-transfected
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siRNA Knockdown of NUP98 Enhances
Viral Particle Formation and Decrease Cell
Viability During Early Phase of Infection
To determine the effect of NUP98 knockdown on infectious
viral particle formation, supernatants were collected from CVB3
infected HeLa cells transfected with scrambled siRNA or siNup98
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FIGURE 4 | siRNA knockdown or overexpression of NUP98 differentially regulates NRG1, ERBB4, PSEN1, and VP-1 expression. (A) HeLa cells were transfected with
scrambled or NUP98 siRNA for 48 h. Cells were subsequently infected with CVB3 or sham-infected with PBS. Cell lysates were harvested at the indicated time-points
for western blot analysis using the indicated antibodies. β-actin was used as a loading control. (B) Quantification of protein expression. Densitometry was performed
on the western blot images using the NIH ImageJ program. The data were normalized against the loading control (n = 3, *p < 0.05) and displayed graphically. Each
scrambled siRNA transfected protein was compared to the corresponding timepoint of siNUP98 transfected cells. (C) HeLa cells were transfected with GFP-NUP98
plasmid or vector only for 48 h and then infected with CVB3 or sham-infected (PBS). Cell lystates were harvested at the indicated time-points for western blot analysis.
(D) Quantification of protein expression. Densitometry and data normalization were performed as described for (B) (n = 3, *p < 0.05) and displayed graphically.

for viral plaque assay as described in the Materials and Methods.
The results show that at 5 hpi the Nup98 knockdown cells had
∼20-fold higher viral titer at the 10−7 dilution than scrambled
siRNA-treated control cells at the sham dilution, even though
a slight increase of CVB3 particles was observed at 7 hpi
(Figure 5A). To determine the effect of siRNA knockdown
of NUP98 on cell viability against viral infection, MTS assay
was performed in CVB3-infected HeLa cells transfected with
scrambled siRNA or siNup98. The sham-infected cells were the
control. At both 5 and 7 hpi, siNUP98 treated wells showed
significantly lower cell viability than scrambled siRNA treated
cells, while no significant difference in cell viability was found
in siNUP98 vs. scrambled siRNA treated sham-infected cells
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(Figure 5B). These results directly support the antiviral role
of NUP98, as Nup98 silencing in CVB3 infection results in
increased cell death while this silencing produces no effect on cell
survival in non-infected states.

Nup98, Nrg1, and erbB4 Are Upregulated in
the Acute Phase but Downregulated in
Later Phase of CVB3 Infected Mouse
Myocardium
To verify our tissue culture findings in an in vivo setting, a
mouse model of viral myocarditis was employed. Four-weeks
old male A/J mice were infected with 104 PFU of CVB3 or
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FIGURE 5 | siRNA knockdown of NUP98 enhances viral particle formation and reduces cell viability. (A) HeLa cells were transfected with scrambled or NUP98 siRNA
for 48 h. Cells were subsequently infected with CVB3 or sham-infected with PBS for 5 or 7 h. Supernatants were collected and used to measure viral particle release
by viral plaque assay. Data were subjected to statistical analysis, n = 3, **p < 0.01. (B) Cell viability assay. HeLa cells were transfected with scrambled siRNA or
siNUP98 for 48 h and then infected with CVB3 or sham-infected with PBS for 5 or 7 h. MTS viability assay was performed. Sham infected control cell viability was set
to 100% survival and other data were converted to percentage of the control, n = 3, *p < 0.05.

indicating the strong immunoreactivity of proteins in the
Nup98-Nrg1-erbB4 signaling axis during acute viral myocarditis
in vivo.

sham-infected with PBS. Hearts were harvested at 7 (acute
infection phase) and 40 (chronic) dpi, corresponding to acute
viral infection and innate immune response. Tissue was lysed
for western blot analysis of Nup98 cleavage and its target gene
expression, or formalin fixed/paraffin embedded and stained by
immunohistochemistry for gene expression and myocarditis. The
results showed that Nup98, Nrg1, and erbB4 were upregulated
during the acute phase of infection (7 dpi) and decreased at
the chronic phase of infection (40 dpi) even though the extent
of decrease for Nup98 expression was small (Figures 6A,B).
Note that at 40 dpi VP1 was non-detectable, implying the
clearance of viral particles by host immune system after the
viremic phase. Myocarditis started to occur after 6 dpi (data
not shown) and reached a higher level at 11 dpi (Figure 6C).
Immunohistochemistry demonstrated that Nup98, Nrg1 and
erbB4 were all upregulated at 7 dpi and downregulated at
40 dpi, a time point of heart recovery from acute infection;
however, at this time point their expression levels were still
higher than that of the sham infected hearts (Figures 6D,E),
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DISCUSSION
The dual functional roles of NUP98 in serving as a nuclear
“gatekeeper” and an immune-responsive transcription factor are
well-documented (Iwamoto et al., 2010; Panda et al., 2014).
NRG1 is a direct transcriptional target gene of NUP98 and
functions along with its receptor ERBB4 in various normal
and pathological conditions including cardiac development,
cancer and neurodegeneration diseases, etc. (Xu et al., 2010;
Simon and Rout, 2014). In addition, PSEN1, a cellular protease
responsible for processing the tyrosine kinase receptor ERBB4,
plays an important role in the NRG1-ERBB4 signaling cascade.
Our studies here provide evidence to demonstrate coordination
between NUP98 and NRG1-ERBB4/PSEN1 signaling proteins in
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FIGURE 6 | Nup98, Nrg1, and erbB4 are upregulated at early phase of infection and were downregulated at later phase in mice. Four-weeks-old A/J mice were
infected with CVB3 at 105 PFU or sham-infected with PBS. Mouse heart tissues were harvested at the indicated days post-infection. (A) Tissue lysates was subjected
to western blot analysis of NUP98 cleavage products and its downstream gene expression using the indicated antibodies. (B) Quantification of protein expression
levels. Densitometry was performed on western blot bands using the NIH ImageJ program as described in Figure 4B (n = 3, *p < 0.05). (C) H&E staining. Tissues
were fixed in formalin and paraffin embedded at time of harvest corresponding to dpi. Images shown are at 10× magnification. Arrows indicate inflammatory
infiltration. (D) Tissue was fixed in formalin and paraffin embedded. Immunohistochemistry was performed using the indicated antibodies. Red staining indicates the
protein of interest. The Images were taken at 10× magnification. Scale bar = 200 µm. (E) Quantification of the expression levels of Nup98, Nrg1, and erbB4 was
conducted using the Aperio ImageScope software. Expression for sham-infected control was set to 1 and relative expression for 7 and 40 dpi was normalized against
the control, n = 3, *p < 0.05.

and increased viral replication; intact NUP98 can potentially
suppress CVB3 replication through its immune-responsive
transcription activity. This finding is in line with the result
obtained from studies in infection of Drosophila by human
arboviruses (Panda et al., 2014).
Disruption of the nuclear pore complex during viral infections
resulting in loss of nuclear membrane integrity and attenuation
of nucleo-cytoplasmic trafficking has been previously described
(Levin et al., 2014; Watters et al., 2017), occurring through
proteolytic cleavage of NUPs, perturbing the balance of molecules
(i.e., RNA and protein) available between the nucleus and
cytoplasm. In the cytoplasm, attenuation of this trafficking will
block nuclear import of proteins, thus leading to accumulation of
certain nuclear proteins, such as the IRES-trans activation factors
(ITAF) La, PTB, Sam68, etc., in the cytosol (Flather and Semler,
2015). Conversely, cleavage of NUPs will increase permeability
of the nuclear membrane, resulting in leaking of nuclear resident
ITAFs to cytoplasm (Belov et al., 2004). The increased availability

the host response to viral infection and identify a previously
unrecognized mechanism of enteroviral pathogenesis of viral
myocarditis. Firstly, we found that NUP98 was cleaved in
HeLa cells during CVB3 infection to produce a ∼55 kDa
fragment at as early as 3 hpi. This cleavage further progressed
to produce a ∼43 kDa product at 4 hpi, indicating that NUP98
protein was cleaved at two sites during CVB3 infection. This
cleavage pattern is similar to that of 2A of poliovirus and
human rhinovirus although the sizes of their cleavage products
are slightly different (Park et al., 2015). To further determine
which protease(s) caused these cleavages, we performed in vitro
cleavage assays using purified recombinant CVB3 2A and 3C
proteases. Only 2A was able to generate the same cleavage
pattern as that produced by CVB3 infection, suggesting that
CVB3 2A but not 3C is responsible for the cleavage of NUP98
protein. Intriguingly, we found that 2A cleavage during infection
corresponded with increased CVB3 VP1 protein production.
This implies a connection between increased NUP98 cleavage
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of ITAFs in cytosol may enhance the IRES-driven translation
of CVB3 genome because its genome harbors an IRES in its
5′ UTR. On the other hand, for the nucleus side, the blockage
of nucleo-cytoplasmic communication will suppress the nuclear
export of mRNAs encoding proteins involved in host antiviral
immune responses. This speculation is supported by previous
findings in several picornavirus studies in which the expression
of proinflammatory cytokines and chemokines as well as antiviral
transcription factors are suppressed due to the shortage of their
mRNAs in cytoplasm (Flather and Semler, 2015; Lloyd, 2015).
All these processes benefit viral replication and are harmful to
cell survival.
Clearly NUP98 cleavage by CVB3 2A plays an important role
in viral pathogenesis. However, we cannot ignore the role of other
partners in this type of mechanism since 2A protease has multiple
cleavage substrates, such as eIF4GI, eIF4GII, PABP, etc.; cleavage
of these proteins can shut down host cap-dependent translation
initiation and in turn promote cap-independent, IRES-driven
translation of enteroviruses (Etchison et al., 1982; Gradi et al.,
1998; Kuyumcu-Martinez et al., 2004). Thus, the proteasemediated viral pathogenesis is a combined effect of cleavage
of multiple substrates. However, it is worth mentioning that
NUP98 is an interferon-inducible transcription factor and plays
a critical role in host immune response against viral infection
(Panda et al., 2014). In addition, NUP98 is very sensitive to viral
protease and can be cleaved by 2A more rapidly and earlier than
eIF4GI cleavage (Park et al., 2008); therefore NUP98 is one of
the cleavage targets that play a major role in viral pathogenesis
compared to other substrates.
In the immune staining for NUP98 subcellular localization,
we found that CVB3 2A-induced NUP98 cleavage elicited further
translocation of NUP98 fragments to the nucleoplasm at early
time point (2 hpi) and subsequently to the cytoplasm in a
punctate pattern at later times (Figure 3). This observation
is similar to what has seen in poliovirus infection (Castello
et al., 2009). This feature may be caused by the gradual
destruction of nuclear membrane by viral protease 2A and/or
other proteases. The punctated pattern of NUP98 distribution
may represent the host cell response to viral insult. Although
the role of these structures during CVB3 infection has yet
to be identified, it is possible that NUP98 localizes to Pbodies, stress granules and/or vesicles for the protection of
cells from viral invasion. This speculation is supported by
similar redistribution patterns induced by other viral infections,
such as poliovirus and human rhinovirus (Lloyd, 2016). In
fact, two recent studies have demonstrated that NUP98 protein
is indeed present in stress granules produced during cellular
stress conditions induced by non-infection conditions (Jain
et al., 2016; Zhang et al., 2018). Interestingly, expression of
viral protease 3C also induced redistribution of NUP98 to
the nucleoplasm, despite no detectable protease effect of 3C
on NUP98 was observed (Figure 3). The likely mechanisms
for this could be that 3C expression causes cleavage of other
unknown substrates of the NUP complex, but this cleavage is
not sufficient for destruction of the nuclear membrane. Thus,
NUP98 is limited in the nucleoplasm without relocation to
cytoplasm. This speculation is indirectly supported by studies of
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human rhinovirus, which demonstrated that human rhinovirus
3C cleaves NUP153, leading to the misallocation of NUPs in
infected host cells (Walker et al., 2013). Whether CVB3 3C can
cleave NUP153 and other NUPs needs to be investigated in
the future.
To further verify the role of NUP98 in regulating target
gene expression and antiviral effect during infection, siRNA
targeting NUP98 was applied to silence its expression. These
data show that knockdown of NUP98 during CVB3 infection
further promoted viral replication, which was evidenced by
the further increase of CVB3 VP1 synthesis and viral progeny
production compared to scrambled siRNA-treated cells at the
5 hpi. However, by 7 hpi the VP1 production in both the
siNUP98-treated and scrambled control siRNA-treated cells
reached similarly high levels, and these levels are significantly
higher than that at 5 hpi in control siRNA-treated cells (Figure 4).
At this later time point, VP1 production in cells with NUP98
knockdown returned to the same level as that of its control
cells, implying knockdown treatment has no effect anymore on
NUP98-mediated regulation of VP1 production as NUP98 could
be completely cleaved. Indeed, at 7 hpi the full-length NUP98
was almost completely absent. Overall, these data support the
notion that NUP98 acts as an antiviral transcription factor during
CVB3 infection.
Furthermore, NRG1 and PSEN1, known for their roles in
cardioprotection (Liu et al., 2006; Li et al., 2011; Galindo
et al., 2014), were further decreased compared to cells treated
with control siRNA. However, ERBB4, the receptor of NRG1,
had a slight decrease at early time-point of infection and
decreased dramatically at 7 hpi. This result suggests that
the genes NRG1 and PSEN1, as the downstream targets
of NUP98, play a positive role with the assistance of
ERBB4 in NUP98-mediated suppression of viral infection and
improvement of host cell viability. This finding on NUP98’s
antiviral effect was further substantiated by ectopic expression
of NUP98, showing the decreased CVB3 replication upon
overexpression of NUP98. These in vitro data were further
substantiated in in vivo experiments. Employing a wellestablished murine model of viral myocarditis, we showed that
Nup98, Nrg1, and erbB4 are all upregulated in the myocardium
during the acute phase (7 dpi). However, at a later chronic
phase of infection (40 dpi), expression of all three were
downregulated. This reduced expression of cardioprotective
genes may contribute to pathogenesis of the disease. Intriguingly,
the expression pattern of proteins in the Nup98-Nrg1-erbB4
signaling cascade is not only limited in infected region but
is enhanced in regions with no inflammation or apparent
tissue damage, suggesting a pathologic field effect. Further
studies are needed to confirm these findings; however, it is
worth mentioning that this finding is valuable because it may
provide sensitive diagnostic markers for human viral myocarditis
as they are expressed at high levels during the early phase
of infection.
Taken together, this study demonstrated that NUP98, an
important regulator of antiviral gene transcription, is targeted
by coxsackievirus protease 2A early on in the model of CVB3
myocarditis. Moreover, we found that cleavage of NUP98 leads
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to the downregulation of cardioprotective genes Nrg1 and
erbB4 in later phase of infection. This finding may provide
evidence to explain, at least in part, why CVB3 infection
causes target cell damage in the heart. In addition, the
immune histopathology studies revealed the timing, location
and expression levels of these proteins involved in the Nup98Nrg1-erbB4 signal cascade. These data are not only valuable
information for adding new diagnostic markers, but also may
provide potential drug targets for developing treatments. To
our knowledge this is the first study linking NUP98 cleavage
and its downstream target gene expression to the molecular
pathogenesis of viral myocarditis.
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